NadA

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameNadA
Drug Alias Namerecombinant bacterial vaccine (University of Southampton)recombinant Neisseria lactamica vaccine (Southampton)4BN14YB2
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsMeningitisSepsisNeisseriaceae Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Southampton
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Southampton
Inactive CompaniesN/A
Active IndicationsMeningitisSepsisNeisseriaceae Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A